Paul McKenzie was appointed Chief Executive Officer and Managing Director of CSL on 6 March 2023. Mr. McKenzie has more than 30 years of leadership experience in the global biotechnology industry, including managing complex organisations …

We are proud to introduce you to our leaders. Chief Executive Officer and Managing Director. Executive Vice President, Legal & General Counsel. Senior Vice President and General Manager, CSL Vifor. Chief Digital Information Officer. Executive Vice President and Chief Strategy Officer. Chief Financial Officer.

Dec 12, 2022 · Currently serving as CSL's Chief Operating Officer (COO), Dr McKenzie, will immediately join the Board of Directors as an Executive Director and will become CEO and Managing Director on 6 March 2023.

Paul McKenzie was appointed Chief Operating Officer in June 2019 and leads CSL’s global end-to-end operations organization and its accompanying strategy. This role includes responsibility for CSL Plasma, manufacturing, quality, engineering, environment, health & …

Dec 12, 2022 · Currently serving as CSL's Chief Operating Officer (COO), Dr McKenzie, will immediately join the Board of Directors as an Executive Director and will become CEO and Managing Director on 6 March...

Dr. Paul McKenzie was appointed Chief Executive Officer and Managing Director of CSL on 6 March 2023. Dr. McKenzie has more than 30 years of leadership experience in the global biotechnology industry, including managing complex organisations through compelling growth and …

Dec 13, 2022 · McKenzie is currently serving as CSL's Chief Operating Officer. He will immediately join the Board of Directors as an Executive Director and will become CEO and Managing Director on 6 March 2023.

Dec 13, 2022 · After spending a decade as the top boss of biotechnology giant CSL (ASX: CSL), managing director and CEO Paul Perreault will hand over the reins to COO Dr Paul McKenzie from March 2023.

Mar 6, 2023 · After nearly four years as CSL’s Chief Operating Officer, this week Dr. Paul McKenzie takes over as CEO. His first stop is Kankakee, Illinois, to visit employees at a CSL Behring manufacturing facility and to see a plasma donation center scheduled to …